South Korea · Delayed Price · Currency is KRW REYON Pharmaceutical Statistics
Total Valuation
KRX:102460 has a market cap or net worth of KRW 183.23 billion. The enterprise value is 398.05 billion.
| Market Cap | 183.23B |
| Enterprise Value | 398.05B |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:102460 has 18.34 million shares outstanding. The number of shares has increased by 0.78% in one year.
| Current Share Class | 18.34M |
| Shares Outstanding | 18.34M |
| Shares Change (YoY) | +0.78% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 81.15% |
| Owned by Institutions (%) | 3.11% |
| Float | 2.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.26 |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.81 |
| EV / Sales | 2.74 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -48.64 |
Financial Position
The company has a current ratio of 0.52, with a Debt / Equity ratio of 1.05.
| Current Ratio | 0.52 |
| Quick Ratio | 0.27 |
| Debt / Equity | 1.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -26.78 |
| Interest Coverage | -2.56 |
Financial Efficiency
Return on equity (ROE) is -17.66% and return on invested capital (ROIC) is -8.04%.
| Return on Equity (ROE) | -17.66% |
| Return on Assets (ROA) | -4.55% |
| Return on Invested Capital (ROIC) | -8.04% |
| Return on Capital Employed (ROCE) | -11.21% |
| Weighted Average Cost of Capital (WACC) | 5.90% |
| Revenue Per Employee | 330.05M |
| Profits Per Employee | -92.24M |
| Employee Count | 448 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 2.88 |
Taxes
In the past 12 months, KRX:102460 has paid 3.93 billion in taxes.
| Income Tax | 3.93B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.18% in the last 52 weeks. The beta is 0.53, so KRX:102460's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | -9.18% |
| 50-Day Moving Average | 10,701.40 |
| 200-Day Moving Average | 11,030.55 |
| Relative Strength Index (RSI) | 38.15 |
| Average Volume (20 Days) | 194,923 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:102460 had revenue of KRW 145.22 billion and -40.59 billion in losses. Loss per share was -2,202.48.
| Revenue | 145.22B |
| Gross Profit | 33.24B |
| Operating Income | -34.35B |
| Pretax Income | -36.65B |
| Net Income | -40.59B |
| EBITDA | -2.49B |
| EBIT | -34.35B |
| Loss Per Share | -2,202.48 |
Balance Sheet
The company has 4.35 billion in cash and 219.17 billion in debt, with a net cash position of -214.82 billion or -11,712.65 per share.
| Cash & Cash Equivalents | 4.35B |
| Total Debt | 219.17B |
| Net Cash | -214.82B |
| Net Cash Per Share | -11,712.65 |
| Equity (Book Value) | 209.58B |
| Book Value Per Share | 11,419.12 |
| Working Capital | -71.04B |
Cash Flow
In the last 12 months, operating cash flow was -3.33 billion and capital expenditures -4.85 billion, giving a free cash flow of -8.18 billion.
| Operating Cash Flow | -3.33B |
| Capital Expenditures | -4.85B |
| Depreciation & Amortization | 31.86B |
| Net Borrowing | 3.58B |
| Free Cash Flow | -8.18B |
| FCF Per Share | -446.21 |
Margins
Gross margin is 22.89%, with operating and profit margins of -23.65% and -27.95%.
| Gross Margin | 22.89% |
| Operating Margin | -23.65% |
| Pretax Margin | -25.24% |
| Profit Margin | -27.95% |
| EBITDA Margin | -1.71% |
| EBIT Margin | -23.65% |
| FCF Margin | n/a |
Dividends & Yields
KRX:102460 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.78% |
| Shareholder Yield | -0.78% |
| Earnings Yield | -22.15% |
| FCF Yield | -4.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 29, 2020 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
KRX:102460 has an Altman Z-Score of 0.9 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.9 |
| Piotroski F-Score | 3 |